Milan Scheidegger: From Molecules to Medicines

Universität Zürich Häldeliweg Map

Milan Scheidegger explores psychedelic drug development, from laboratory discoveries to clinical care, drawing on translational research with DMT-based formulations.

From Molecules to Medicines: Inside Psychedelic Drug Development

PD Dr. med. Milan Scheidegger

How does a promising psychedelic compound become a treatment patients can benefit from? This lecture offers a behind-the-scenes perspective on psychedelic drug development, exploring the scientific questions and practical decisions that connect laboratory discoveries with clinical care. Drawing on his translational research with DMT-based formulations, Milan Scheidegger discusses the interplay between pharmacology and therapeutic context, alongside key clinical and regulatory challenges. At the intersection of neuroscience, psychiatry and biotechnology, the talk examines the opportunities and open questions on the path towards approved psychedelic treatments.

Tuesday 1 December 2026, 18:30

University of Zurich · HAH-E-03

Häldeliweg 2, 8044 Zürich

Organised by PROZ – Psychedelic Research Organization Zurich.

https://www.psychedelicresearchzurich.ch/